50881-0044 JAKAFI XR - CanMED: NDC

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50881-0044

Brand Name:

JAKAFI XR

Generic Name:

Ruxolitinib

Dosage Form Name:

TABLET, EXTENDED RELEASE

Administration Route:

Oral

Substances:

Name: RUXOLITINIB

Strength: 44.0

Unit: mg/1

Packages:

Code: 50881-0044-08

Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50881-044-08)

Effective Date: May 1, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

JAK 1/2

Orphan Drug Designation:

Status:

In Use